INTRODUCTION
============

Conventional magnetic resonance (MR) imaging \[e.g., contrast-enhanced T1-weighted (CE-T1) imaging with gadolinium and fluid attenuated inversion recovery imaging)\] has been recommended for reliable delineation of intracranial tumors ([@B1][@B2]). However, because high-grade gliomas often diffusely infiltrate surrounding normal brain tissues, morphology-based target delineation using conventional MR imaging and computed tomography (CT) can miss lesions that should be included in the treatment volumes ([@B3][@B4][@B5]). Enlarging clinical target volumes (CTVs) to encompass suspicious regions which are not visible on CT and CE-T1 images of high-grade gliomas can hinder dose optimization for local high-risk regions. Moreover, image-based target definition including the tumor bed is even more critical for residual tumors after incomplete surgical resection to ensure coverage of the neoplastic regions and prevent recurrence ([@B6]). Thus, various attempts have been made to improve the radiation treatment outcome of high-grade gliomas by integrating multi-modal imaging, beam intensity-modulated techniques, and other adjuvant therapies ([@B7][@B8][@B9][@B10]).

However, high-grade gliomas showed poor survival rates and frequent recurrence, even within the pre-irradiated gross tumor volume (GTV) receiving higher doses than marginal tumors ([@B10]). It CTV delineation considering physiological and histopathological characteristics of the tumor and dose optimization to high-risk regions that may be positively applied to create more effective treatment plans ([@B11]).

One of the characteristics for high-grade gliomas is increase of cellularity during tumor progression ([@B12]). Apparent diffusion coefficient (ADC) maps reconstructed from diffusion-weighted (DW) MR images can describe histopathological information about cellularity in high-grade gliomas ([@B2]), by providing a quantitative index of restricted water diffusion in intracellular spaces relative to extracellular spaces ([@B13]). Enhanced regions of malignant gliomas with compact cellularity on ADC maps (aCTV~HR~) can be used to define high-risk CTV ([@B14][@B15][@B16]) and doses were optimized to the aCTV~HR~.

In this study, we defined aCTV~HR~ on the ADC maps by making reference to the reported quantitative ADC criteria which indicates malignancy level of high-grade gliomas. The benefits of aCTV~HR~-targeted dose optimization were assessed in dose distributions of an intensity-modulated radiation therapy (IMRT) plan based on ADC values (IMRT~ADC~) as compared with a conventional IMRT (IMRT~conv~) plan.

MATERIALS AND METHODS
=====================

Image acquisition
-----------------

A patient was diagnosed with a high-grade glioma (grade III) in the right anterior temporal lobe and basal ganglia of the brain. After surgical resection of the tumor, ADC images of the cavity showed a suspicious malignant lesion; therefore, adjuvant radiation therapy was performed according to the National Comprehensive Cancer Network practice guidelines ([@B17]). To determine residual tumor volumes, we examined perfusion-weighted, MR spectroscopy, and DW images along with conventional MR and CT images.

MR imaging and CT were performed using a 1.5-Tesla MR unit (GE SIGNA system, GE Medical Systems, Milwaukee, WI, USA) and a GE 9800 Quick System CT scanner (GE Medical Systems), respectively. CE-T1 imaging used gadolinium as the contrast agent and a spin echo T1-weighted sequence with a time to echo (TE) value of 500 ms and a repetition time (TR) of 13 ms. The ADC maps were constructed from DW images that were scanned over 3 orthogonal diffusion gradients with 2 different gradient factors (b=0, 1,000 s/mm^2^) using a TE of 75 ms and a TR of 8,000 ms. To obtain reliable signal-to-ratio and consider clinically practical application of ADC maps, commonly applied b-value of 1,000 s/mm^2^ was used ([@B18]).

Incorporation of ADCs into the radiation treatment plan
-------------------------------------------------------

ADC values were used to verify the severity of the residual malignant lesion and to differentiate the aCTV~HR~ from the tumor bed. Average, maximum, and minimum ADC values and ADC ratios (rADCs) were calculated using MATLAB (version 7.10.0.499, MathWorks, Natick, MA, USA). To reduce variability in the selection of the boundaries of tumor regions, ADC values were evaluated in the compact rectangular volumes of interest (VOIs) covering all apices of the suspected regions closely surrounding hypo-intense voxels on ADC maps. Then, volumetric averaged ADC values were evaluated within the expanded VOIs (VOIs with at least a 2-cm margin on each side). Because high-grade gliomas often contain cystic or necrotic regions, we averaged the ADC values from 3-5 regions of interest (ROIs, 2-3 mm^2^ each) in the expanded VOIs. The rADC is obtained from the ADC of the aCTV~HR~ divided by the ADC of the volume in contralateral normal brain tissues.

The aCTV~HR~ showing a lower ADC value than the averaged ADC value was extracted via computational analysis and image processing of ADC maps. The extracted aCTV~HR~ was re-marked on the ADC maps (pixel intensity equal to the maximum pixel intensity of the original ADC map). The ADC values were also confirmed by comparing with those reported for high-grade gliomas in diagnostic studies.

Because quantitative analysis of ADC maps and extraction of aCTV~HR~ by applying the ADC criteria were not possible in commercial planning system (Eclipse, version 7.3.1, Varian Medical Systems, Palo Alto, CA, USA), two kinds of CT images were imported into Eclipse: the original CT images and another CT images including the aCTV~HR~ and the CE-T1 image-based CTV (tCTV). To obtain the contours of the aCTV~HR~ and tCTV on CT images using more reliable image registration functions, two sets of images (ADC map vs. CE-T1, CE-T1 vs. CT) were registered using BrainSCAN (version 5.31, BrainLab, Munich, Heimstetten, Germany). The overall procedure used to incorporate the determined aCTV~HR~ into radiation treatment plans is shown in [Fig. 1](#F1){ref-type="fig"}.

We also referred to the converted DW ratio to confirm volumes with low diffusion levels on DW-MR images. The DW-ratio maps were obtained by normalizing the original DW images to the average diffusion intensity of corresponding contralateral normal brain tissues.

Treatment plans
---------------

To evaluate dose distribution in the IMRT~ADC~ plan, the following tumor volumes were contoured on each CT image: CE-T1-based GTV (tGTV), ADC-based CTV (aCTV~HR~), and relative complement volume of aCTV~HR~ in tCTV (sCTV) ([Fig. 2](#F2){ref-type="fig"}).The tCTV is tGTV plus a 2.0-cm margin (1.5 cm for microscopic spread and 0.5 cm for set-up uncertainty). The CTV margin adjacent to critical structures, such as the right optic nerve, optic chiasm, and pituitary gland, was compromised to spare organs at risk (OARs).

The IMRT~ADC~ plan was optimized to deliver 60 Gy to the aCTV~HR~ via the simultaneous integrated boost (SIB) technique ([@B2][@B17][@B19]). Because the ADC maps indicated the differentiated aCTV~HR~ from the residual tumor, the tumor bed needed to receive the required dose of 50 Gy ([@B16]). However, because the IMRT~conv~ plan was based only on conventional CE-T1 images, which showed the tumor bed but not CTV~HR~ at the specific position, the tCTV received 60 Gy. The other plan parameters were equally applied to both plans, and they are summarized in [Table 1](#T1){ref-type="table"}. To provide a conformal dose to CTVs, 5 coplanar fields with different gantry angles (70°, 130°, 250°, 270°, and 310°) and 2 non-coplanar fields (60°/60° and 300°/300° for gantry/couch angles, respectively) were used.

Evaluation of dose distributions
--------------------------------

Dose distributions in the two plans were evaluated using biophysical indices for plan comparison and dose volume histograms (DVHs) for the aCTV~HR~ and the tCTV. The homogeneity and conformity of dose distributions in the CTV were analyzed using the statistically modified homogeneity index (s-index) and the conformity number (CN), respectively ([@B20][@B21]). The s-index and CN were evaluated using the prescribed doses (59.4 Gy for the aCTV~HR~ and 50.4 Gy for the tCTV). Dosimetric effects were evaluated on the basis of the equivalent uniform dose (EUD) of the two plans according to a linear quadratic model for the tumor ([@B22][@B23]) and a power law for the OARs ([@B24]). Tumor control probability (TCP) based on Poisson statistics was compared for the aCTV~HR~ in both plans ([@B25]). In addition, the EUD-based figure-of-merit (f-EUD) was calculated for comprehensive plan evaluation using the EUD value of each primary structure ([@B24]). The weighting factors and the relative importance in f-EUD were assumed to be 1 in this study. Formulas and radiobiological parameters to evaluate dose distributions and calculate biophysical values are summarized in Appendix A and B ([@B26][@B27][@B28]).

Ethics statement
----------------

This study protocol was approved by the institutional review board (IRB) of Konkuk University Medical Center (IRB No. KUH 1280065). Informed consent was waived by the board.

RESULTS
=======

Clinical target volumes in multimodal images and apparent diffusion coefficients
--------------------------------------------------------------------------------

Conventional CT images did not clearly distinguish between the high-risk CTV and normal brain tissues ([Fig. 3A](#F3){ref-type="fig"}). The resection cavity was enhanced by the contrast medium in the CE-T1 images ([Fig. 3B](#F3){ref-type="fig"}), but the histopathological characteristics of the high-risk CTV were not apparent. In contrast, the DW images and ADC maps could reveal residual high-risk CTV as enhanced and suppressed regions, respectively ([Fig. 3C, D](#F3){ref-type="fig"}). In the converted color map of the DW image, the diffusion values for the high-risk CTV were more than two-fold higher than those for normal brain tissues. Higher intensity regions appear red or orange in [Fig. 3E](#F3){ref-type="fig"}.

The average ADC of the high-risk CTV was (0.73±0.23)×10^-3^ mm^2^/s, and the average rADC was (0.67±0.32)×10^-3^ mm^2^/s; both were less than 1×10^-3^ mm^2^/s. The minimum ADC of the high-risk CTV was 0.37×10^-3^ mm^2^/s, which is lower than the ADCs reported in medical diagnostic studies of high-grade gliomas \[(0.86±0.12)×10^-3^ mm^2^/s and (0.82±0.13)×10^-3^ mm^2^/s for average ADC and rADC, respectively\] ([@B15][@B29]). The volumes with values lower than the average ADCs were defined as aCTV~HR~ ([Fig. 3F](#F3){ref-type="fig"}).

Plan evaluation
---------------

Dose distributions in two IMRT plans were evaluated using DVHs and various dosimetric metrics. The IMRT~ADC~ plan, which focused on dose optimization for the aCTV~HR~, produced a well-confined conformal dose distribution around the aCTV~HR~ within the prescribed 60-Gy isodose surface (fluorescent green in [Fig. 4A](#F4){ref-type="fig"}). Because dose conformity is mainly affected by the size of the total volume which received dose more than prescribed value (V~RI~) (area surrounded by fluorescent green line in [Fig. 4B](#F4){ref-type="fig"}), the aCTV~HR~-targeted dose distribution resulted in less irradiation of the V~RI~. The IMRT~ADC~ plan improved the dose conformity of the aCTV~HR~ up to 15 times, compared to the IMRT~conv~ plan ([Table 2](#T2){ref-type="table"}). In addition, the IMRT~ADC~ plan showed superior dose uniformity of the aCTV~HR~ by 7%, as indicated by a lower s-index in this plan compared with that of the IMRT~conv~ plan.

Although the IMRT~ADC~ plan slightly increased the EUD (61.42 Gy vs. 60.00 Gy in the IMRT~ADC~ and IMRT~conv~ plans, respectively) and the TCP (26.67 % vs. 24.01%, respectively), the differential DVHs of the aCTV~HR~ were comparable in both plans ([Fig. 5A](#F5){ref-type="fig"}). The DVHs showed greater dose sparing of OARs in the IMRT~ADC~ plan ([Fig. 5B](#F5){ref-type="fig"}), owing to differences in dose optimization with and without focusing on the aCTV~HR~. The tailored dose delivery in the IMRT~ADC~ plan reduced EUDs by up to 16% in the brain stem and right lens ([Table 3](#T3){ref-type="table"}) and by more than 10% in the right optic nerve, optic chiasm, and left lens. Lower EUDs in these OARs could lead to an increase in f-EUDs in the IMRT~ADC~ plan.

DISCUSSION
==========

Combining DW images and ADC maps with conventional CT and CE-T1 images can bring advantages in cancer diagnosis and therapy. In some cases, especially those involving high-grade gliomas with a rim that is not enhanced by contrast agents on CE-T1 images, DW images and ADC maps can help delineate CTVs by detecting pathologically relevant tumor characteristics not seen on conventional morphological images ([@B5]). As the large CTV is located close to critical organs, determination of image-based anisotropic target margin becomes more important for reducing toxicity in normal tissues. When we adopt DW images into radiotherapy plans for such as determination of target margins and high-risk CTV mentioned above, more rigorous image analysis and multimodality image-based confirmation of target volumes can support reliable application of advanced functional MR images.

Moreover, because DW images can show physiological and pathological variations of tumor to evaluate treatment responses through rapid and noninvasive scanning ([@B30]), those can be considered as an appropriate and powerful tool for adaptive radiation treatment plans. Patients can be monitored without additional radiation exposure during fractionated radiation treatment.

As application of extra-cranial DW images for patients with breast, prostate, and liver cancers ([@B31]) and the advent of a MRI-linac hybrid machine gradually become widespread, the role of DW images or ADC maps to define CTV becomes more important ([@B32]). Image-based dose optimization, especially targeting to the high-risk CTV, may facilitate effective and delicate dose delivery using dose painting techniques ([@B33]).

In conclusion, the aCTV~HR~ was determined via quantitative analysis of ADC maps of a residual high-grade glioma. The IMRT~ADC~ plan in combination with DW images and ADC maps showed optimized dose distribution to the aCTV~HR~ with dense cellularity. Incorporating ADC maps into radiation treatment plans for high-grade gliomas may help achieve biophysical dose optimization in local high-risk tumor volumes.
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APPENDIX A
==========

Dose homogeneity and conformity are evaluated with statistical model and conformity number, respectively, using following equations (1) and (2):
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Equivalent uniform dose (EUD) for target volumes and organs at risk (OAR) are calculated using equations (3) and (4):
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Tumor control probability (TCP) and EUD-based figure-of-merit (f-EUD) for principal structures are analyzed using equations, (5) and (6):
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The parameters used in the formula are described in the table below.

ParametersDefinitionD~i~delivered dose to the *i*-th voxel*v~T~^i^*corresponding target volume of *i*-th voxelD~p~prescribed doseV~T~total target volumeV~RI~corresponding volume to the reference isodoseV~T,\ RI~target volume covered by the reference isodose

![](jkms-30-1522-a002)

  Type             Radiobiological parameters                                          
  ---------------- ------------------------------------- ---- ------ ----- ----------- ---------------
  Target           High grade glioma (Primary culture)   10   72.7   -10   1.5         Local control
  Normal tissues   Brain                                 3    60     5     3           Necrosis
  Brainstem                                              65   7      3     Necrosis    
  Optic Chiasm                                           65   25     3     Blindness   
  Lens                                                   18   3      1     Cataract    
  Optic Nerve                                            65   25     3     Blindness   
  Retina                                                 65   15     2     Blindness   

^\*^α/β, linear and quadratic term in dose at linear quadratic model of cell survival curve; ^†^TCD50, required dose for 50% control probability of tumor; ^‡^TD50, radiation dose that results in a 50% severe complication rate of normal tissues; ^§^a, biological model parameter to calculate equivalent uniform dose; ^∥^γ50, normalized slope at the 50% tumor control probability.

![Overall procedures used in the conventional intensity-modulated radiation therapy (IMRT~conv~) and an apparent diffusion coefficient (ADC) map-based IMRT (IMRT~ADC~) plans. The left flow chart connected with black lines describes the general and common procedures to create two IMRT plans. The blue dashed line corresponds to the IMRT~conv~ plan. Additionally required procedures for the IMRT~ADC~ were presented with orange line.](jkms-30-1522-g001){#F1}

![The delineated target volumes in the intensity-modulated radiation therapy plan. The ADC-based high-risk clinical target volume (aCTV~HR~), contrast enhanced T1 image-based gross tumor volume (tGTV) and CTV (tCTV). The aCTV~HR~ is defined on ADC maps by applying the ADC criteria for high-grade glioma to extract the high-risk residual target volume. The tCTV is defined by adding a 2-cm margin to the tGTV.](jkms-30-1522-g002){#F2}

![Multi-modal and post-processed images used to determine the high-risk tumor volume in a high-grade glioma. (**A**) Computed tomography image. (**B**) Contrast enhanced-T1 weighted image. (**C**) Diffusion-weighted (DW) image (b=1,000 s/mm^2^). (**D**) ADC map. (**E**) DW ratio map with normalized average diffusion values of the contralateral normal brain tissues. The red and orange regions represent double- and triple-restricted water diffusion, respectively. (**F**) Extracted malignant residual tumor volumes on ADC maps with quantitative analysis for suspicious high-risk lesions.](jkms-30-1522-g003){#F3}

![Comparison of the dose distributions in the IMRT~conv~ plan and IMRT~ADC~ plan. (**A**) Dose distribution in the IMRT~ADC~ plan. Prescribed doses of 59.4 Gy and 50.4 Gy were optimized to the aCTV~HR~ and relative complement volume of aCTV~HR~ in tCTV (sCTV), respectively, using the simultaneous integrated boost technique. (**B**) Dose distribution in the IMRT~conv~ plan. A dose of 59.4 Gy was prescribed to the tCTV.](jkms-30-1522-g004){#F4}

![Comparison of the dose volume histograms (DVHs) in the IMRT~conv~ and the IMRT~ADC~ plans. (**A**) Differential DVHs for the residual clinical target volumes at high risk on the ADC maps. Horizontal axis: doses normalized to the prescribed dose (59.4 Gy). (**B**) Cumulative DVHs for organs at risk.](jkms-30-1522-g005){#F5}

###### Planning parameters for conventional intensity-modulated radiation therapy (IMRT~conv~) and IMRT based on apparent diffusion coefficient (ADC) maps (IMRT~ADC~). Both plans were based on contrast enhanced (CE)-T1 weighted images

![](jkms-30-1522-i001)

  Plan         Images           Total dose (Gy)      Fraction number (fx)   Daily dose (Gy/fx)   Fields and beam delivery techniques
  ------------ ---------------- -------------------- ---------------------- -------------------- -----------------------------------------------------------------
  IMRT~ADC~    CE-T1^\*^        59.4 (aCTV~HR~^‡^)   28                     2.12                 5 coplanar fields + 2 non-coplanar fields + SIB^\*\*^ technique
  DW-MR^†^     50.4 (sCTV^¶^)                        1.8                                         
  ADC^§^                                                                                         
  CT^ll^                                                                                         
  IMRT~conv~   CE-T1            59.4 (tCTV^††^)      33                     1.8                  5 coplanar fields + 2 non-coplanar fields
  CT                                                                                             

^\*^CE-T1, contrast enhanced-T1 weighted; ^†^DW-MR, diffusion weighted-magnetic resonance; ^‡^aCTV~HR~, clinical target volume (CTV) at high risk determined based on the ADC maps; ^§^ADC, apparent diffusion coefficient; ^∥^CT, computed tomography; ^¶^sCTV, the relative complement volume of aCTV~HR~ in tCTV, tCTV- (tCTV∩aCTV~HR~); ^\*\*^SIB, simultaneous integrated boost; ^††^tCTV, CTV delineated on the CE-T1 images by expanding gross tumor volume with a 2-cm margin.

###### Evaluation of dose distributions using homogeneity (s-index) and conformity indices (conformity number) for the target volumes, aCTV~HR~ showing malignancy of high-grade gliomas on ADC maps and tCTV defined on CE-T1 images
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                          Volume        IMRT~ADC~^\*^   IMRT~conv~^†^
  ----------------------- ------------- --------------- ---------------
  Homogeneity (s-index)   aCTV~HR~^‡^   1.49            1.60
  tCTV^§^                 3.26          10.48           
  Conformity (CN)         aCTV~HR~      0.48            0.032
  tCTV                    0.94          0.71            

^\*^IMRT~ADC~, intensity-modulated radiation therapy (IMRT) plan optimized to aCTV~HR~ and tCTV using simultaneous integrated boost; ^†^IMRT~conv~, conventional IMRT plan using CE-T1 images for tCTV; ^‡^aCTV~HR~, clinical target volume at high risk defined on the ADC maps; ^§^tCTV, expanded tGTV (gross tumor volume on CE-T1 images) with a 2-cm margin.

###### Evaluation of the equivalent uniform doses (EUDs) for organs at risk (OARs) and EUD-based figure-of-merit (f-EUD) in the IMRT~ADC~ and the IMRT~conv~ plans
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  Plan         EUD \[Gy\]                                                  
  ------------ ------------ ------ ------- ------- ------- ------- ------- ------
  IMRT~ADC~    1.09         3.40   17.87   36.09   35.56   35.95   30.17   0.14
  IMRT~conv~   1.21         3.91   18.60   41.19   39.12   41.62   34.99   0.12

^\*^fEUD, EUD-based figure-of-merit to evaluate plan quality using EUDs for structures of interest.

[^1]: ^\*^Ji-Yeon Park and Tae Suk Suh contributed equally to this work.
